Rami Batal - Net Worth and Insider Trading
Rami Batal Net Worth
The estimated net worth of Rami Batal is at least $8,310 dollars as of 2024-09-21. Rami Batal is the Senior Officer of Antibe Therapeutics Inc and owns about 28,169 shares of Antibe Therapeutics Inc (TSX:ATE) stock worth over $8,310. Details can be seen in Rami Batal's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rami Batal has not made any transactions after 2020-09-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rami Batal
Rami Batal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rami Batal owns 1 companies in total, including Antibe Therapeutics Inc (TSX:ATE) .
Click here to see the complete history of Rami Batal’s form 4 insider trades.
Insider Ownership Summary of Rami Batal
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSX:ATE | Antibe Therapeutics Inc | 2020-09-21 | Senior Officer |
Rami Batal Latest Holdings Summary
Rami Batal currently owns a total of 1 stock. Rami Batal owns 28,169 shares of Antibe Therapeutics Inc (TSX:ATE) as of September 21, 2020, with a value of $8,310.
Latest Holdings of Rami Batal
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSX:ATE | Antibe Therapeutics Inc | 2020-09-21 | 28,169 | 0.30 | 8,310 |
Holding Weightings of Rami Batal
Rami Batal Form 4 Trading Tracker
According to the SEC Form 4 filings, Rami Batal has made a total of 1 transactions in Antibe Therapeutics Inc (TSX:ATE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Antibe Therapeutics Inc is the acquisition of 28,169 shares on September 21, 2020, which cost Rami Batal around $98,592.
Insider Trading History of Rami Batal
- 1
Rami Batal Trading Performance
GuruFocus tracks the stock performance after each of Rami Batal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rami Batal is 3.71%. GuruFocus also compares Rami Batal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rami Batal within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rami Batal's insider trading performs compared to the benchmark.
Rami Batal Ownership Network
Rami Batal Owned Company Details
What does Antibe Therapeutics Inc do?
Who are the key executives at Antibe Therapeutics Inc?
Rami Batal is the Senior Officer of Antibe Therapeutics Inc. Other key executives at Antibe Therapeutics Inc include Director & Director or Senior Officer of 10% Security Holder & Senior Officer John Lawrence Wallace , Senior Officer Joseph Stauffer , and Senior Officer Scott Wilson Curtis .
Antibe Therapeutics Inc (TSX:ATE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antibe Therapeutics Inc (TSX:ATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antibe Therapeutics Inc (TSX:ATE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antibe Therapeutics Inc (TSX:ATE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antibe Therapeutics Inc Insider Transactions
Rami Batal Mailing Address
Above is the net worth, insider trading, and ownership report for Rami Batal. Currently GuruFocus does not have mailing address information for Rami Batal.